3-Ethoxycarbonyl-1,4-benzodioxin-2-carboxylic Acid
Abstract
:1. Introduction
2. Results and Discussion
3. Materials and Methods
3-Ethoxycarbonyl-1,4-benzodioxin-2-carboxylic Acid (3)
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bolchi, C.; Bavo, F.; Appiani, R.; Roda, G.; Pallavicini, M. 1,4-Benzodioxane, an evergreen, versatile scaffold in medicinal chemistry: A review of its recent applications in drug design. Eur. J. Med. Chem. 2020, 200, 112419. [Google Scholar] [CrossRef] [PubMed]
- Muszak, D.; Surmiak, E.; Plewka, J.; Magiera-Mularz, K.; Kocik-Krol, J.; Musielak, B.; Sala, D.; Kitel, R.; Stec, M.; Weglarczyk, K.; et al. Terphenyl-based small-molecule inhibitors of programmed cell death-1/programmed death-ligand 1 protein-protein interaction. J. Med. Chem. 2021, 64, 11614–11636. [Google Scholar] [CrossRef] [PubMed]
- Lu, Y.; Vibhute, S.; Li, L.; Okumu, A.; Ratigan, S.C.; Nolan, S.; Papa, J.L.; Mann, C.A.; English, A.; Chen, A.; et al. Optimization of TopoIV potency, ADMET properties, and hERG inhibition of 5-amino-1,3-dioxane-linked novel bacterial topoisomerase inhibitors: Identification of a lead with in vivo efficacy against MRSA. J. Med. Chem. 2021, 64, 15214–15249. [Google Scholar] [CrossRef] [PubMed]
- Pasqua, A.E.; Sharp, S.Y.; Chessum, N.E.A.; Hayes, A.; Pellegrino, L.; Tucker, M.J.; Miah, A.; Wilding, B.; Evans, L.E.; Rye, C.S.; et al. HSF1pahway inhibitor clinical candidate (CCT361814/NXP800) developed from a phenotypic screen as a potential treatment for refractory ovarian cancer and other malignancies. J. Med. Chem. 2023, 66, 5907–5936. [Google Scholar] [CrossRef] [PubMed]
- Bavo, F.; Pallavicini, M.; Gotti, C.; Appiani, R.; Moretti, M.; Colombo, S.F.; Pucci, S.; Viani, P.; Budriesi, R.; Renzi, M.; et al. Modifications at C(5) of 2-(2-pyrrolidinyl)-substituted 1,4-benzodioxane elicit potent α4β2 nicotinic acetylcholine receptor partial agonism with high selectibity over the α3β4 subtype. J. Med. Chem. 2020, 63, 15668–15692. [Google Scholar] [CrossRef] [PubMed]
- Bavo, F.; Pallavicini, M.; Appiani, R.; Bolchi, C. Determinants for α4β2 vs. α3β4 subtype selectivity of pyrrolidine-based nAChRs ligands: A computational perspective with focus on recent cryo-EM receptor structures. Molecules 2021, 26, 3603. [Google Scholar] [CrossRef] [PubMed]
- Bolchi, C.; Valoti, E.; Straniero, V.; Ruggeri, P.; Pallavicini, M. From 2-aminomenthyl-1,4-benzodioxane enantiomers to unichiral 2-cyano- and 2-carbonyl-substituted benzodioxanes via dichloroamine. J. Org. Chem. 2014, 79, 6732–6737. [Google Scholar] [CrossRef] [PubMed]
- Bouissane, L.; Khouili, M.; Coudert, G.; Pujol, M.D.; Guillaumet, G. New and promising type of leukotriene B4 (LTB4) antagonists based on the 1,4-benzodioxine structure. Eur. J. Med. Chem. 2023, 254, 115332. [Google Scholar] [CrossRef] [PubMed]
- Armano, E.; Giraudo, A.; Pallavicini, M.; Bolchi, C. Methyl 8- and 5-bromo-1,4-benzodioxane-2-carboxylate: Unambiguous identification of the two regioisomers. Molbank 2023, 2023, M1623. [Google Scholar] [CrossRef]
- Armano, E.; Giraudo, A.; Morano, C.; Pallavicini, M.; Bolchi, C. Methyl 8- and 5-nitro-1,4-benzodioxane-2-carboxylate. Molbank 2023, 2023, M1661. [Google Scholar] [CrossRef]
- Yin, X.; Huang, Y.; Chen, Z.; Hu, Y.; Tao, L.; Zhao, Q.; Dong, X.Q.; Zhang, X. Enantioselective access to chiral 2-substituted 2,3-dihydrobenzo[1,4]dioxane derivatives through Rh-catalyzed asymmetric hydrogenation. Org. Lett. 2018, 20, 4173–4177. [Google Scholar] [CrossRef] [PubMed]
- Lalloz, L.; Loppinet, V.; Coudert, G.; Guillaumet, G.; Loubinoux, B.; Labrid, C.; Beaughard, M.; Dureng, G.; Lamar, J.C. 2-Benzodioxinylaminoethanols: A new class of β-adrenergic blocking and antihypertensive agents. J. Med. Chem. 1981, 24, 994–998. [Google Scholar] [CrossRef] [PubMed]
- Ramanathan, V.; Levine, R. Some reactions of 2-furyllithium. J. Org. Chem. 1962, 27, 1216–1219. [Google Scholar] [CrossRef]
- Knight, D.W. Formation and reactivity of bis-anions derived from furoic acids. Tetrahedron Lett. 1979, 20, 469–472. [Google Scholar] [CrossRef]
- Guillaumet, G.; Coudert, G.; Loubinoux, B. Synthese de benzodioxines-1,4 disubstituees sur l’heterocycle. Tetrahedron Lett. 1979, 20, 4379–4382. [Google Scholar] [CrossRef]
- Pearson, A.J.; Roush, W.R. Activating Agents and Protecting Groups; John Wiley & Sons: Chichester, UK, 1999; pp. 183–184. [Google Scholar]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Armano, E.; Giraudo, A.; Morano, C.; Pallavicini, M.; Bolchi, C. 3-Ethoxycarbonyl-1,4-benzodioxin-2-carboxylic Acid. Molbank 2024, 2024, M1873. https://doi.org/10.3390/M1873
Armano E, Giraudo A, Morano C, Pallavicini M, Bolchi C. 3-Ethoxycarbonyl-1,4-benzodioxin-2-carboxylic Acid. Molbank. 2024; 2024(3):M1873. https://doi.org/10.3390/M1873
Chicago/Turabian StyleArmano, Edoardo, Alessandro Giraudo, Camillo Morano, Marco Pallavicini, and Cristiano Bolchi. 2024. "3-Ethoxycarbonyl-1,4-benzodioxin-2-carboxylic Acid" Molbank 2024, no. 3: M1873. https://doi.org/10.3390/M1873
APA StyleArmano, E., Giraudo, A., Morano, C., Pallavicini, M., & Bolchi, C. (2024). 3-Ethoxycarbonyl-1,4-benzodioxin-2-carboxylic Acid. Molbank, 2024(3), M1873. https://doi.org/10.3390/M1873